Approximately 12% of patients with diabetes in general population studies have CHF (Figure 5.1) (Nichols etal., 2001; Thrainsdottir etal., 2005), and in diabetic
Diabetic Cardiolog Editors Miles Fisher and John J. McMurray © 2007 John Wiley & Sons, Ltd. ISBN: 978-0-470-86204-9
Figure 5.1 The prevalence of CHF in men and women in the Rekjavik population study. Reproduced from Thrainsdottir IS, Aspelund T, Thorgeirsson G, Gudnason V, Hardarson T, Malmberg K et al. (2005). The association between glucose abnormalities and heart failure in the population-based Reykjavik study. Diabetes Care 28: 612-16.
patients over 64 years of age the prevalence of CHF rises to 22% (Bertoni etal., 2004).
All large-scale clinical trials on glycaemia in patients with diabetes have either excluded patients with CHF by design (UK Prospective Diabetes Study (UKPDS) Group, 1998; The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group, 2005) or not reported CHF as a co-morbidity.
Was this article helpful?